Publication:
Evaluation Of Difference In Levothyroxine Withdrawal Period And Its Effects On Thе Level Of Thyroid Stimulating Hormone And Quality Of Life In Differentiated Thyroid Carcinoma Patients

Simple item page
dc.contributor.authorKhalil, Mohammad Fitri
dc.date.accessioned2026-05-19T02:32:18Z
dc.date.available2026-05-19T02:32:18Z
dc.date.issued2020
dc.description.abstractTitle: Evaluation of difference in levothyroxine withdrawal period and its effects on the level of thyroid stimulating hormone (TSH) and quality of life (QoL) in differentiated thyroid carcinoma patients. Introduction: Most patients with DTC require radioactive iodine (RAI) ablation therapy using 1-131. The preparation prior to RAI ablation includes withdrawal of levothyroxine for at least four weeks in order to raise the TSH level of more than 30 mIU/L. During 4 weeks of levothyroxine withdrawal, most patients develop symptoms of hypothyroidism. Reducing the period of levothyroxine withdrawal period from 4 weeks to 3 weeks could improve patient's overall health and QoL. Objective: To evaluate the difference in levothyroxine withdrawal period and its effect on the level of TSH and QoL. Methods: DTC patients who require RAI ablation therapy was recruited into this study. Thyroid function test and SF-36 questionnaire were conducted at week 3 and week 4 of levothyroxine withdrawal period. Clinical data was analysed using IBM SPSS version 26.0.0. Results: A total of 104 patients with the mean age of 47.06 years were recruited. Most of them were female (80.77%) and Malays (53.85%). Papillary thyroid carcinoma accounted for 77.88% of the patients. Stage 1 disease was the largest group with 67.31% whilst stage 3 was the smallest group with 6.73%. At week 3 of levothyroxine withdrawal, 88.46% of the patients were able to achieve TSH level of more than 30 mIU/L with means of 66.89 mIU/L, compared to 99.04% at week 4 of levothyroxine withdrawal. Cohen kappa measurement of agreement between week 3 and week 4 was 0.139. There was a significant reduction in the quality of life in week 4 compared to week 3 in all components (p <0.050). There were no significant association between the staging of the disease and TSH level at week 3 and week 4. Conclusion: 88.46% of the patients had achieved TSH level of more than 30 mIU/L after 3 weeks of levothyroxine withdrawal. However, 4 weeks of levothyroxine withdrawal is still more superior compared to 3 weeks. There was better QoL in the overall health and quality of life in week 3 compared to week 4.
dc.identifier.urihttps://erepo.usm.my/handle/123456789/24255
dc.language.isoen
dc.subjectEvaluation Of Difference
dc.subjectPeriod And Its Effects
dc.subjectThyroid Stimulating Hormone
dc.subjectCarcinoma
dc.subjectAMDI
dc.titleEvaluation Of Difference In Levothyroxine Withdrawal Period And Its Effects On Thе Level Of Thyroid Stimulating Hormone And Quality Of Life In Differentiated Thyroid Carcinoma Patients
dc.typeResource Types::text::thesis::master thesis
dspace.entity.typePublication
oairecerif.author.affiliationUniversiti Sains Malaysia
Files
Collections
Institut Perubatan & Pergigian Termaju - Tesis